Disposition and covalent binding of diflunisal and diflunisal acyl glucuronide in the isolated perfused rat liver

Drug Metabolism and Disposition

Volumn 26, Issue 2, 1998, Pages 98-104

  Wang, Min ^a   Dickinson, Ronald G ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CARBOXYLIC ACID DERIVATIVE; CLOFIBRIC ACID; DIFLUNISAL; GEMFIBROZIL; GLUCURONIDE; MEFENAMIC ACID; SALICYLIC ACID DERIVATIVE; SULFATE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; COVALENT BOND; DRUG BILE LEVEL; DRUG CLEARANCE; DRUG CONCENTRATION; DRUG CONFORMATION; DRUG CONJUGATION; DRUG DISPOSITION; DRUG ELIMINATION; DRUG EXCRETION; DRUG GLUCURONIDATION; DRUG HALF LIFE; DRUG HYDROLYSIS; GLYCATION; IMMUNOBLOTTING; LIVER MICROSOME METABOLISM; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REACTION ANALYSIS;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DIFLUNISAL; GLUCURONATES; LIVER; MALE; METABOLIC DETOXICATION, DRUG; MOLECULAR STRUCTURE; PERFUSION; PROTEINS; RATS; SULFATES;

ANIMALIA;

EID: 0031940440     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Bailey MJ and Dickinson RG (1996) Chemical and immunochemical comparison of protein adduct formation of four carboxylate drugs in rat liver and plasma. Chem Res Toxicol 9:659-666.
2. Benet LZ, Spahn-Langguth H, Iwakawa S, Volland C, Mizuma T, Mayer S, Muttchler E and Lin ET (1993) Predictability of the covalent binding of acidic drugs in man. Life Sci (Washington DC) 53:141-146.
3. Boelsterli UA, Zimmerman HJ and Kretz-Rommel A (1995) Idiosyncratic liver toxicity of nonsteroidal antiinflammatory drugs: Molecular mechanisms and pathology. Crit Rev Toxicol 25:207-235.
4. Dickinson RG and King AR (1989) Reactivity considerations in the analysis of glucuronide and sulfate conjugates of diflunisal. Ther Drug Monit 11:712-720.
5. Dickinson RG and King AR (1991) Studies on the reactivity of acyl glucuronides: II. Interaction of diflunisal acyl glucuronide and its isomers with human serum albumin in vitro. Biochem Pharmacol 42:2301-2306.
6. Dickinson RG and King AR (1993) Studies on the reactivity of acyl glucuronides: V. Glucuronide-derived covalent binding of diflunisal to bladder tissue of rats and its modulation by urinary pH and β-glucuronidase. Biochem Pharmacol 46:1175-1182.
7. Dickinson RG, Baker PV and King AR (1994) Studies on the reactivity of acyl glucuronides: VII. Salicyl acyl glucuronide reactivity in vitro and covalent binding of salicylic acid to plasma protein of humans taking aspirin. Biochem Pharmacol 47:469-476.
8. Dickinson RG, King AR and Hauen-Møller J (1991) The sulphate conjugate of diflunisal: Its synthesis and systemic stability in the rat Xenobiatica 21:635-640.
9. Dickinson RG, Kluck RM, Wood BT. Eadie MI and Hooper WD (1986) Impaired biliary elimination of β-glucuronidase-resiaant "glucuronides" of valproic acid after intravenous administration in the rat: Evidence for oxidative metabolism of the resistant isomers. Drug Metab Dispos 14:255-262.
10. Ding A, Ojingwa JC, McDonagh AF, Burlingame AL and Benet LZ (1993) Evidence for covalent binding of acyl glucuronides to serum albumin via an imine mechanism as revealed by tandem mass spectrometry. Proc Natl Acad Sci USA 90:3797-3801.
11. Ding A, Zia-Amirhosseini P, McDonagh AF, Burlingame AL and Benet LZ (1995) Reactivity of tolmetin glucuronide with human serum albumin: Identification of binding sites and mechanisms of reaction by tandem mass spectrometry. Drug Metab Dispos 23:369-376.
12. Faed EM (1984) Properties of acyl glucuronides: Implications for studies of the pharmacokinetics and metabolism of acidic drugs. Drug Metab Rev 15:1213-1249.
13. Fenselau C (1994) Acyl glucuronides as chemically reactive intermediates. Handbook Exp Pharmacol 112:367-389.
14. Hargus SJ, Amouzedeh HR, Pumford NR, Myers TG, McCoy SC and Pohl LR (1994) Metabolic activation and immunochemical localization of liver protein adducts of the non-steroidal anti-inflammatory drug diclofenac. Chem Res Toxicol 7:575-582.
15. Hargus SJ, Martin BM, George JW and Pohl LR (1995) Covalent modification of rat liver dipeptidyl peptidase IV (CD26) by the nonsteroidal anti-inflammatory drug diclofenac. Chem Res Toxicol 8:993-996.
16. Hirom PC, Millburn P and Smith RL (1976) Bile and urine as complementary pathways for the excretion of foreign organic compounds. Xenobiotica 6:55-64.
17. King AR and Dickinson RG (1991) Studies on the reactivity of acyl glucuronides: I. Phenolic glucuronidation of isomers of diflunisal acyl glucuronide in the rat. Biochem Pharmacol 42:2289-2299.
18. King AR and Dickinson RG (1993) Studies on the reactivity of acyl glucuronides: IV. Covalent binding of diflunisal to tissues of the rat. Biochem Pharmacol 45:1043-1047.
19. Klaassen CD and Watkins JB (1984) Mechanisms of bile formation, hepatic uptake and biliary excretion. Pharmacol Rev 36:1-67.
20. Kretz-Rommel A and Boelsterli UA (1993) Diclofenac covalent protein binding is dependent on acyl glucuronide formation and is inversely related to P450-medicated acute cell injury in cultured rat hepatocytes. Toxicol Appl Pharmacol 120:155-161.
21. Kretz-Rommel A and Boelsterli UA (1994a) Mechanism of covalent adduct formation of diclofenac to rat hepatic microsomal proteins: Retention of the glucuronic acid moiety in the adduct. Drug Metab Dispos 22:956-961.
22. Kretz-Rommel A and Boelsterli UA (1994b) Selective protein adducts to membrane proteins in cultured rat hepatocytes exposed to diclofenac: Radiochemical and immunochemical analysis. Mol Pharmacol 45:237-244.
23. McGurk KA, Remmel RP, Hosagrahara VP, Tosh D and Burchell B (1996) Reactivity of mefenamic acid 1-O-acyl glucuronide with proteins in vitro and ex vivo. Drug Metab Dispos 24:842-849.
24. Sallustio BC, Fairchild BA and Pannall PR (1997) Interaction of human serum albumin with the electrophilic metabolite 1-O-gemfibrozil-β-D-glucuronide. Drug Metab Dispos 25:55-60.
25. Sallustio BC, Knights KM, Roberts BJ and Zacest R (1991) In vitro covalent binding of clofibric acid to human plasma proteins and rat liver proteins. Biochem Pharmacol 42:1421-1425.
26. Shaklai N, Garlick RL and Bunn HF (1984) Nonenzymatic glycosylation of human serum albumin alters its conformation and function. J Biol Chem 259:3812-3817.
27. Shore LJ, Fenselau C, King AR and Dickinson RG (1995) Characterization and formation of the glutathione conjugate of clofibric acid. Drug Metab Dispos 23:119-123.
28. Smith PC and Liu JH (1995) Covalent binding of suprofen to renal tissue of rat correlates with excretion of its acyl glucuronide. Xenobiotica 25:531-540.
29. Smith PC, Benet LZ and McDonagh AF (1990) Covalent binding of zomepirac glucuronide to proteins: Evidence for a Schiff base mechanism. Drug Metab Dispos 18:639-644.
30. Smith PC, McDonagh AF and Benet LZ (1986) Irreversible binding of zomepirac to plasma protein in vitro and in vivo. J Clin Invest 77:934-939.
31. Spahn-Langguth H and Benet LZ (1992) Acyl glucuronides revisited: Is the glucuronidation process a toxification as well as a detoxification mechanism? Drug Metab Rev 24:5-47.
32. Tsang VC, Peralta JM and Simons AR (1983) Enzyme-linked immunotransfer Blot techniques (EITB) for studying the specificities of antigens and antibodies. Methods Enzymol 92:377-391.
33. van Breeman RB and Fenselau C (1985) Acylation of albumin by 1-O-acyl glucuronides. Drug Metab Dispos 13:318-320.
34. Watt JA, King AR and Dickinson RG (1991) Contrasting systemic stabilities of the acyl and phenolic glucuronides of diflunisal in the rat. Xenobiotica 21:403-415.
35. Williams AM and Dickinson RG (1994) Studies on the reactivity of acyl glucuronides: VI. Modulation of reversible and covalent interaction of diflunisal acyl glucuronide and its isomers with human plasma protein in vitro. Biochem Pharmacol 47:457-467.
36. Worrall S and Dickinson RG (1995) Rat serum albumin modified by diflunisal acyl glucuronide is immunogenic in rats. Life Sci (Washington DC) 56:1921-1930.
37. Zia-Amirhosseini P, Harris RZ, Brodsky FM and Benet LZ (1995) Hypersensitivity to nonsteroidal anti-inflammatory drugs. Nat. Med. 1:2-4.